Express Scripts's most recent trend suggests a bullish bias. One trading opportunity on Express Scripts is a Bull Put Spread using a strike $77.50 short put and a strike $72.50 long put offers a potential 12.11% return on risk over the next 27 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $77.50 by expiration. The full premium credit of $0.54 would be kept by the premium seller. The risk of $4.46 would be incurred if the stock dropped below the $72.50 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Express Scripts is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Express Scripts is bullish.
The RSI indicator is at 78.57 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Express Scripts
See what the IHS Markit Score report has to say about Express Scripts Holding Co.
Thu, 18 Jan 2018 13:07:32 +0000
Express Scripts Holding Co NASDAQ/NGS:ESRX
Super Savings: Inside Rx Expands Its Prescription Savings Program, Offers Discounts on 100 Brand Name Medications
Wed, 17 Jan 2018 12:00:00 +0000
– Inside Rx Generated $35 Million in Savings Since May 2017 – 30 new brand medications for weight loss, dermatology, gastrointestinal conditions and allergies now available FRANKLIN LAKES, N.J. , Jan. …
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
Mon, 15 Jan 2018 18:54:25 +0000
Louis, Jan. 15, 2018– Express Scripts Holding Company announced today its intention to release its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018, after the market closes …
Express Scripts 90-Day Analysis of Opioid Management Positive
Mon, 15 Jan 2018 13:27:01 +0000
Express Scripts (ESRX) addresses the national opioid epidemic by reducing excessive and improper opioid use.
Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients
Thu, 11 Jan 2018 19:00:00 +0000
WASHINGTON, Jan. 11, 2018 /PRNewswire/ — During a briefing on meaningful solutions for safer opioid prescribing with Congressional Representatives Ann McLane Kuster (D-NH) and Tom MacArthur (R-NJ), Express Scripts (ESRX) today announced that an initial 90-day review of its Advanced Opioid ManagementSM program shows that the comprehensive solution is protecting people using an opioid medication, particularly those taking an opioid for the first time. In the first 90 days since the program began on September 1, 2017, the company observed a nearly 60 percent reduction in the average days supply for patients receiving an opioid prescription for the first time, from 18.6 days supply per prescription claim before the launch of the program, to 7.5 days supply per claim after the start of the program.
Also on Market Tamer…
Follow Us on Facebook